$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 10,000 | 0 | 34,724 | 24.7 K to 34.7 K (+40.45 %) |
| Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 8,333 | 0 | 24,724 | 16.4 K to 24.7 K (+50.84 %) |
| Jan 03 2018 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
| Jan 03 2018 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Payment of Exercise | F | 5.95 | 5,670 | 33,737 | 4,330 | 10 K to 4.3 K (-56.70 %) |
| Jan 03 2018 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Oct 24 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 33,333 | 0 | 66,667 | |
| Oct 24 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 7.03 | 18,759 | 131,876 | 23,851 | 42.6 K to 23.9 K (-44.02 %) |
| Oct 24 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 33,333 | 0 | 42,610 | 9.3 K to 42.6 K (+359.31 %) |
| Aug 03 2017 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 10.07 | 2,250 | 22,667 | 93,846 | 96.1 K to 93.8 K (-2.34 %) |
| Aug 01 2017 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | M | 0.00 | 6,767 | 0 | 6,767 | |
| Aug 01 2017 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Buy | M | 0.00 | 6,767 | 0 | 138,785 | 132 K to 138.8 K (+5.13 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 8.19 | 12,125 | 99,304 | 179,375 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 7.10 | 3,888 | 27,605 | 131,615 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 8.19 | 2,500 | 20,475 | 191,500 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 7.10 | 6,997 | 49,679 | 135,503 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.90 | 9,253 | 63,846 | 4,092 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.30 | 1,250 | 7,875 | 2,500 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 10,000 | 60,000 | 0 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.90 | 23,876 | 164,744 | 13,345 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.30 | 6,124 | 38,581 | 3,750 | |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 10.19 | 12,125 | 123,496 | 59,839 | 72 K to 59.8 K (-16.85 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 8.19 | 12,125 | 99,304 | 71,964 | 59.8 K to 72 K (+20.26 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 10.28 | 3,888 | 39,969 | 59,839 | 63.7 K to 59.8 K (-6.10 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 7.10 | 3,888 | 27,605 | 63,727 | 59.8 K to 63.7 K (+6.50 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 10.00 | 2,500 | 25,000 | 59,839 | 62.3 K to 59.8 K (-4.01 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 8.19 | 2,500 | 20,475 | 62,339 | 59.8 K to 62.3 K (+4.18 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 10.00 | 6,997 | 69,970 | 59,839 | 66.8 K to 59.8 K (-10.47 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 7.10 | 6,997 | 49,679 | 66,836 | 59.8 K to 66.8 K (+11.69 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.92 | 9,253 | 91,810 | 59,839 | 69.1 K to 59.8 K (-13.39 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.90 | 9,253 | 63,846 | 69,092 | 59.8 K to 69.1 K (+15.46 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 10.00 | 1,250 | 12,500 | 59,839 | 61.1 K to 59.8 K (-2.05 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.30 | 1,250 | 7,875 | 61,089 | 59.8 K to 61.1 K (+2.09 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 10.00 | 10,000 | 100,000 | 59,839 | 69.8 K to 59.8 K (-14.32 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.00 | 10,000 | 60,000 | 69,839 | 59.8 K to 69.8 K (+16.71 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.90 | 23,876 | 236,372 | 59,839 | 83.7 K to 59.8 K (-28.52 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.90 | 23,876 | 164,744 | 83,715 | 59.8 K to 83.7 K (+39.90 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.30 | 6,124 | 56,953 | 59,839 | 66 K to 59.8 K (-9.28 %) |
| Jul 13 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.30 | 6,124 | 38,581 | 65,963 | 59.8 K to 66 K (+10.23 %) |
| Jul 10 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.30 | 290 | 1,827 | 9,874 | |
| Jul 10 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.30 | 19,587 | 123,398 | 10,164 | |
| Jul 10 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.30 | 290 | 2,697 | 59,839 | 60.1 K to 59.8 K (-0.48 %) |
| Jul 10 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.30 | 290 | 1,827 | 60,129 | 59.8 K to 60.1 K (+0.48 %) |
| Jul 10 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.30 | 19,587 | 182,159 | 59,839 | 79.4 K to 59.8 K (-24.66 %) |
| Jul 10 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.30 | 19,587 | 123,398 | 79,426 | 59.8 K to 79.4 K (+32.73 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.30 | 18,009 | 113,457 | 29,751 | |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 7.10 | 11,991 | 85,136 | 142,500 | |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 7.10 | 5,509 | 39,114 | 154,491 | |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 7.10 | 30,000 | 213,000 | 160,000 | |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.30 | 18,009 | 167,484 | 59,839 | 77.8 K to 59.8 K (-23.13 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.30 | 18,009 | 113,457 | 77,848 | 59.8 K to 77.8 K (+30.10 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.12 | 11,991 | 109,387 | 59,839 | 71.8 K to 59.8 K (-16.69 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 7.10 | 11,991 | 85,136 | 71,830 | 59.8 K to 71.8 K (+20.04 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.11 | 5,509 | 50,167 | 59,839 | 65.3 K to 59.8 K (-8.43 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 7.10 | 5,509 | 39,114 | 65,348 | 59.8 K to 65.3 K (+9.21 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 9.12 | 30,000 | 273,669 | 59,839 | 89.8 K to 59.8 K (-33.39 %) |
| Jun 30 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 7.10 | 30,000 | 213,000 | 89,839 | 59.8 K to 89.8 K (+50.13 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 0.00 | 12,912 | 0 | 12,912 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Buy | M | 0.00 | 20,362 | 0 | 69,184 | 48.8 K to 69.2 K (+41.71 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 12,912 | 0 | 12,912 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 20,362 | 0 | 45,671 | 25.3 K to 45.7 K (+80.45 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Buy | M | 0.00 | 20,362 | 0 | 132,018 | 111.7 K to 132 K (+18.24 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Grant | A | 0.00 | 12,912 | 0 | 111,656 | 98.7 K to 111.7 K (+13.08 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Buy | M | 0.00 | 20,362 | 0 | 96,096 | 75.7 K to 96.1 K (+26.89 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Grant | A | 0.00 | 12,912 | 0 | 75,734 | 62.8 K to 75.7 K (+20.55 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 12,912 | 0 | 44,218 | 31.3 K to 44.2 K (+41.24 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 20,362 | 0 | 53,849 | 33.5 K to 53.8 K (+60.81 %) |
| May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Grant | A | 0.00 | 12,912 | 0 | 33,487 | 20.6 K to 33.5 K (+62.76 %) |
| May 03 2017 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 7.31 | 4,000 | 29,228 | 62,822 | 66.8 K to 62.8 K (-5.99 %) |
| Feb 03 2017 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 7.32 | 4,000 | 29,290 | 66,822 | 70.8 K to 66.8 K (-5.65 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,333 | 0 | 26,667 | |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Payment of Exercise | F | 7.40 | 7,088 | 52,451 | 59,839 | 66.9 K to 59.8 K (-10.59 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 0.00 | 13,333 | 0 | 66,927 | 53.6 K to 66.9 K (+24.88 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 26,821 | 115,330 | 0 | |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.51 | 26,821 | 201,305 | 16,391 | 43.2 K to 16.4 K (-62.07 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 26,821 | 115,330 | 43,212 | 16.4 K to 43.2 K (+163.63 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Payment of Exercise | F | 7.40 | 4,442 | 32,871 | 16,391 | 20.8 K to 16.4 K (-21.32 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 8,333 | 0 | 20,833 | 12.5 K to 20.8 K (+66.66 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 20,000 | 0 | 40,000 | |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 7.40 | 10,723 | 79,350 | 9,277 | 20 K to 9.3 K (-53.61 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 66,667 | |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 7.40 | 17,955 | 132,867 | 2,155,045 | 2.2 M to 2.2 M (-0.83 %) |
| Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,173,000 | 2.1 M to 2.2 M (+1.56 %) |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.90 | 2,044 | 14,104 | 37,221 | |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 2,500 | 15,000 | 0 | |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 4,168 | 25,008 | 10,000 | |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.69 | 6,668 | 57,928 | 53,594 | 60.3 K to 53.6 K (-11.07 %) |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.00 | 6,668 | 40,008 | 60,262 | 53.6 K to 60.3 K (+12.44 %) |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.90 | 2,044 | 18,192 | 53,594 | 55.6 K to 53.6 K (-3.67 %) |
| Dec 20 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.90 | 2,044 | 14,104 | 55,638 | 53.6 K to 55.6 K (+3.81 %) |
| Dec 07 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 30,000 | 180,000 | 14,168 | |
| Dec 07 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.50 | 30,000 | 255,000 | 53,594 | 83.6 K to 53.6 K (-35.89 %) |
| Dec 07 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.00 | 30,000 | 180,000 | 83,594 | 53.6 K to 83.6 K (+55.98 %) |
| Nov 23 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.30 | 1,250 | 7,875 | 47,760 | |
| Nov 23 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.30 | 1,250 | 10,375 | 53,594 | 54.8 K to 53.6 K (-2.28 %) |
| Nov 23 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.30 | 1,250 | 7,875 | 54,844 | 53.6 K to 54.8 K (+2.33 %) |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 2,698 | 16,188 | 44,168 | |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 7,302 | 43,812 | 46,866 | |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 22,698 | 136,188 | 0 | |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 6.00 | 634 | 3,804 | 22,698 | |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.00 | 2,698 | 21,584 | 53,594 | 56.3 K to 53.6 K (-4.79 %) |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.00 | 2,698 | 16,188 | 56,292 | 53.6 K to 56.3 K (+5.03 %) |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.00 | 30,000 | 240,000 | 53,594 | 83.6 K to 53.6 K (-35.89 %) |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.00 | 30,000 | 180,000 | 83,594 | 53.6 K to 83.6 K (+55.98 %) |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Sell | S | 8.00 | 634 | 5,072 | 53,594 | 54.2 K to 53.6 K (-1.17 %) |
| Nov 14 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 6.00 | 634 | 3,804 | 54,228 | 53.6 K to 54.2 K (+1.18 %) |
| Nov 07 2016 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Option Exercise | J | 0.00 | 30,120 | 0 | 0 | |
| Nov 07 2016 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 31,306 | 0 | 31,306 | 0 to 31.3 K |
| Nov 03 2016 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 6.10 | 4,000 | 24,411 | 70,822 | 74.8 K to 70.8 K (-5.35 %) |
| Oct 26 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 6.23 | 50,000 | 311,500 | 50,000 | |
| Oct 26 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Oct 19 2016 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Option Exercise | A | 0.00 | 30,120 | 0 | 30,120 | |
| Sep 02 2016 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 5.07 | 4,000 | 20,262 | 74,822 | 78.8 K to 74.8 K (-5.07 %) |
| Jul 29 2016 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | M | 0.00 | 6,767 | 0 | 13,534 | |
| Jul 29 2016 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Buy | M | 0.00 | 6,767 | 0 | 98,744 | 92 K to 98.7 K (+7.36 %) |
| May 27 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
| May 27 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
| May 27 2016 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
| May 27 2016 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
| May 27 2016 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Buy | M | 0.00 | 11,795 | 0 | 78,822 | 67 K to 78.8 K (+17.60 %) |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 4.39 | 5,544 | 24,337 | 20,575 | 26.1 K to 20.6 K (-21.23 %) |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 11,795 | 0 | 26,119 | 14.3 K to 26.1 K (+82.34 %) |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Buy | M | 0.00 | 11,795 | 0 | 48,822 | 37 K to 48.8 K (+31.86 %) |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
| May 24 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 11,795 | 0 | 25,309 | 13.5 K to 25.3 K (+87.28 %) |
| May 18 2016 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Buy | P | 4.05 | 50,000 | 202,500 | 91,977 | 42 K to 92 K (+119.11 %) |
| May 16 2016 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Buy | P | 4.05 | 25,000 | 101,213 | 41,977 | 17 K to 42 K (+147.26 %) |
| May 13 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 4.03 | 40,000 | 161,388 | 99,600 | 59.6 K to 99.6 K (+67.11 %) |
| May 12 2016 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | A | 2.10 | 180,000 | 378,000 | 180,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | A | 3.57 | 110,000 | 392,700 | 110,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 3.57 | 65,000 | 232,050 | 65,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 3.57 | 190,000 | 678,300 | 190,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 3.57 | 300,000 | 1,071,000 | 300,000 | |
| Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Jan 22 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 15,127 | 30,254 | 0 | |
| Jan 22 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 10,637 | 21,274 | 15,127 | |
| Jan 22 2016 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 4.06 | 15,127 | 61,429 | 0 | 15.1 K to 0 (-100.00 %) |